Hence, their results highlight that in NSCLC, the clonality and diversity of TCR from circulating PD-1 + CD8 + T cells are promising non-invasive predictive indicators of response to ICIs and survival prognosis in NSCLC, which was supported by a subsequent study [85]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.